Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215690.RAzpALdas_hkF-EhbRS_F2m4V4eZT8-TXEiprBooj3HL0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215690.RAzpALdas_hkF-EhbRS_F2m4V4eZT8-TXEiprBooj3HL0130_assertion type Assertion NP1215690.RAzpALdas_hkF-EhbRS_F2m4V4eZT8-TXEiprBooj3HL0130_head.
- NP1215690.RAzpALdas_hkF-EhbRS_F2m4V4eZT8-TXEiprBooj3HL0130_assertion description "[Multivariate analysis indicated that adenocarcinoma (P<0.05), lymph node metastasis (P<0.05), advanced TNM stage (P<0.001) and reduced expression of LKB1 (P<0.05) and Beclin1 (P<0.001) are all independent prognostic indicators for the survival of NSCLC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215690.RAzpALdas_hkF-EhbRS_F2m4V4eZT8-TXEiprBooj3HL0130_provenance.
- NP1215690.RAzpALdas_hkF-EhbRS_F2m4V4eZT8-TXEiprBooj3HL0130_assertion evidence source_evidence_literature NP1215690.RAzpALdas_hkF-EhbRS_F2m4V4eZT8-TXEiprBooj3HL0130_provenance.
- NP1215690.RAzpALdas_hkF-EhbRS_F2m4V4eZT8-TXEiprBooj3HL0130_assertion SIO_000772 25175672 NP1215690.RAzpALdas_hkF-EhbRS_F2m4V4eZT8-TXEiprBooj3HL0130_provenance.
- NP1215690.RAzpALdas_hkF-EhbRS_F2m4V4eZT8-TXEiprBooj3HL0130_assertion wasDerivedFrom befree-2016 NP1215690.RAzpALdas_hkF-EhbRS_F2m4V4eZT8-TXEiprBooj3HL0130_provenance.
- NP1215690.RAzpALdas_hkF-EhbRS_F2m4V4eZT8-TXEiprBooj3HL0130_assertion wasGeneratedBy ECO_0000203 NP1215690.RAzpALdas_hkF-EhbRS_F2m4V4eZT8-TXEiprBooj3HL0130_provenance.